STARLIMS Announces Exercise of Over-Allotment Option by Underwriters

Offering Results in Total Net Proceeds for the Company of $27 Million


HOLLYWOOD, Fla., June 27, 2007 (PRIME NEWSWIRE) -- STARLIMS Technologies Ltd. (Nasdaq:LIMS) today announced that in connection with the company's May 2007 initial public offering in the United States, Oppenheimer & Co. and JMP Securities LLC have exercised part of their over-allotment option and have purchased an additional 126,300 ordinary shares from the company.

STARLIMS has sold a total of 2,226,300 ordinary shares (including the over-allotment option shares) at a price to the public of $13.50 per share, resulting in net proceeds from the offering of approximately US$27 million.

Oppenheimer & Co. is acting as sole bookrunning manager of the offering and JMP Securities LLC is acting as co-lead manager of the offering. This offering of ordinary shares is being made only by means of a prospectus. Copies of the final prospectus may be obtained from Oppenheimer & Co. Inc. at 125 Broad Street, 16th Floor, New York, New York 10004 and JMP Securities LLC at 600 Montgomery Street, Suite 1100, San Francisco, California 94111.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor will there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About STARLIMS

STARLIMS Technologies Ltd. (Nasdaq:LIMS) is a leading provider of laboratory information management systems (LIMS), with over 20 years of LIMS experience. The company's flagship product, STARLIMS(r), improves the reliability of laboratory sampling processes, supports compliance with domestic and international regulations and industry standards, and provides comprehensive reporting, monitoring and analysis capabilities. STARLIMS software is used for quality assurance and control, testing and monitoring, and research and development in government, manufacturing and life sciences organizations. With operations in the United States, Canada, the United Kingdom, Israel and Hong Kong, the company serves over 500 organizations in 40 countries. Please see www.starlims.com for more information.



            

Contact Data